Skip to main content

Corazon (Corsee) D. Sanders

Equibles does not estimate personal net worth.

Get an email with a short summary when Ultragenyx Pharmaceutical Inc. publishes a filing, an earnings call transcript or a press release.

Get RARE alerts

About Corazon (Corsee) D. Sanders

Corazon (Corsee) D. Sanders is recorded as Board Member at Ultragenyx Pharmaceutical Inc. (RARE) since June 29, 2021. Ultragenyx Pharmaceutical Inc. reported in an 8-K filed June 30, 2021 that Corazon (Corsee) D. Sanders was appointed Class II director, effective June 29, 2021. Ultragenyx Pharmaceutical Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ultragenyx Pharmaceutical Inc. includes Emil D. Kakkis (CEO and Board Member), Emil Kakkis (CEO and Board Member), Howard Horn (CFO) and 7 others.

“On June 29, 2021, the Board of Directors (the “Board”) of Ultragenyx Pharmaceutical Inc. (the “Company”) appointed Corazon (Corsee) D. Sanders, Ph.D. a Class II director of the Board effective June 29, 2021 (the “Effective Date”) to serve until the expiration of her term at the 2024 annual meeting of stockholders.”
Ultragenyx Pharmaceutical Inc. Form 8-K, filed June 30, 2021 · Read the filing

Affiliation history

Company network

Leadership on record at Ultragenyx Pharmaceutical Inc.

Recent activity